ArticleCancer research and treatment2021

Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells.

Hye-Yon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.